News
General
2 views
Doceree names Yesh Srinivasan chief AI officer
Jun 15, 2026
đź“Ť Philadelphia, PA, USA
🤖🏥 Healthcare technology company **Doceree** has strengthened its artificial intelligence leadership team by appointing Indian American technology executive **Yeshwanth Srinivasan** as its first-ever Chief AI Officer, signaling the company’s growing focus on advanced data intelligence and AI-driven healthcare innovation.
With more than **18 years of experience** in machine learning, data science, and large-scale engineering systems, Srinivasan brings an impressive track record of building AI-powered platforms across advertising technology, digital media, and analytics. Before joining Doceree, he served as Vice President of Data Science and Engineering at TripleLift, where he helped scale operations to process more than **500 billion advertising requests daily** while contributing to numerous patents and technical innovations.
His appointment comes ahead of Doceree’s highly anticipated launch of **Daily Command**, an AI-powered platform designed to help pharmaceutical and healthcare teams analyze real-time clinical insights, optimize marketing strategies, and make faster data-driven decisions. The company believes AI can play a transformative role in improving communication between healthcare providers, life sciences organizations, and patients.
Originally from Tamil Nadu, India, Srinivasan earned his engineering degree from **SASTRA University** before moving to the United States to complete his master’s and Ph.D. in Electrical and Computer Engineering at **Texas Tech University**. His academic research focused on medical imaging and computer vision, making healthcare AI a natural extension of his professional journey.
Working closely with Doceree’s innovation leadership, Srinivasan is expected to develop advanced predictive intelligence systems that move beyond traditional generative AI applications and focus on specialized healthcare and clinical use cases. As AI becomes increasingly important across medicine, pharmaceuticals, and patient engagement, his appointment highlights the growing role Indian American technology leaders continue to play in shaping the future of healthcare innovation worldwide. 🚀📊💡
With more than **18 years of experience** in machine learning, data science, and large-scale engineering systems, Srinivasan brings an impressive track record of building AI-powered platforms across advertising technology, digital media, and analytics. Before joining Doceree, he served as Vice President of Data Science and Engineering at TripleLift, where he helped scale operations to process more than **500 billion advertising requests daily** while contributing to numerous patents and technical innovations.
His appointment comes ahead of Doceree’s highly anticipated launch of **Daily Command**, an AI-powered platform designed to help pharmaceutical and healthcare teams analyze real-time clinical insights, optimize marketing strategies, and make faster data-driven decisions. The company believes AI can play a transformative role in improving communication between healthcare providers, life sciences organizations, and patients.
Originally from Tamil Nadu, India, Srinivasan earned his engineering degree from **SASTRA University** before moving to the United States to complete his master’s and Ph.D. in Electrical and Computer Engineering at **Texas Tech University**. His academic research focused on medical imaging and computer vision, making healthcare AI a natural extension of his professional journey.
Working closely with Doceree’s innovation leadership, Srinivasan is expected to develop advanced predictive intelligence systems that move beyond traditional generative AI applications and focus on specialized healthcare and clinical use cases. As AI becomes increasingly important across medicine, pharmaceuticals, and patient engagement, his appointment highlights the growing role Indian American technology leaders continue to play in shaping the future of healthcare innovation worldwide. 🚀📊💡
Tags
news
Comments (0)
Login to post comments
No comments yet
Be the first to share your thoughts about this post.